| scholarly article | Q13442814 |
| P2093 | author name string | T J Peters | |
| G D Smith | |||
| R Mahler | |||
| T A Amos | |||
| P2860 | cites work | Hypoglycaemia and antimalarial drugs: quinidine and release of insulin. | Q34285953 |
| Extraction of Insulin by Liver | Q39927378 | ||
| Mode of uptake and degradation of 125I-labelled insulin by isolated hepatocytes and H4 hepatoma cells | Q41852662 | ||
| Degradation of endocytosed insulin in rat liver is mediated by low-density vesicles | Q41917057 | ||
| In Vivo Chloroquine-induced Inhibition of Insulin Degradation in a Diabetic Patient with Severe Insulin Resistance | Q41918190 | ||
| The effects of low temperature and chloroquine on 125I-insulin degradation by the perfused rat liver | Q41924374 | ||
| Insulin resistance: a common feature of diabetes mellitus. | Q54425071 | ||
| Insulin processing by the liver | Q70239908 | ||
| The localization in rat liver of alkaline phosphodiesterase to a discrete organelle implicated in ligand internalization | Q72529681 | ||
| P433 | issue | 6570 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chloroquine | Q422438 |
| preproinsulin | Q7240673 | ||
| P1104 | number of pages | 3 | |
| P304 | page(s) | 465-467 | |
| P577 | publication date | 1987-02-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Effect of chloroquine on insulin and glucose homoeostasis in normal subjects and patients with non-insulin-dependent diabetes mellitus | |
| P478 | volume | 294 |
| Q34389286 | A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role |
| Q47681831 | ATP-dependent desensitization of insulin binding and tyrosine kinase activity of the insulin receptor kinase. The role of endosomal acidification |
| Q36073241 | Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial |
| Q34129797 | Antimalarials. |
| Q92037499 | COVID-19 and diabetes management: What should be considered? |
| Q41932285 | Chloroquine augments the binding of insulin to its receptor. |
| Q90018752 | Chloroquine differentially modulates coronary vasodilation in control and diabetic mice |
| Q41925505 | Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail |
| Q69903359 | Does chloroquine cause hypoglycaemia in the absence of clinical malaria? |
| Q37799813 | Drug-induced hypoglycaemia: an update |
| Q33740539 | Drug-induced hypoglycemia |
| Q37977342 | Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II). |
| Q35638692 | High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors |
| Q35519392 | Hydroxychloroquine as a glucose lowering drug |
| Q96768081 | Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story |
| Q41953362 | Hydroxychloroquine: a diabetic drug in disguise? |
| Q37827403 | Hydroxychloroquine: from malaria to autoimmunity |
| Q41924532 | Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats |
| Q52537565 | Intracellular hyperinsulinism: a metabolic characteristic of obesity with and without Type 2 diabetes: intracellular insulin in obesity and Type 2 diabetes. |
| Q35153962 | Management of Non-Insulin-Dependent Diabetes Mellitus |
| Q34007922 | New concepts in antimalarial use and mode of action in dermatology |
| Q47841128 | Non-radioisotopic glucose turnover in children with falciparum malaria and enteric fever. |
| Q41292997 | Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications |
| Q41917902 | The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial |
| Q41918499 | The inhibition of gluconeogenesis by chloroquine contributes to its hypoglycaemic action. |
| Q40696805 | Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review |
| Q36240014 | Type II Diabetes and Syndrome X: Pathogenesis and Glycemic Management |
Search more.